Biotest Aktiengesellschaft Capital Reinvestment Ratio
Biotest Aktiengesellschaft capital reinvestment ratio. Biotest Aktiengesellschaft (BIO) has a Capital Reinvestment Ratio of 0.50x as of December 2023, meaning it reinvests 0% of its operating cash flow (€67.40 Million) in capital expenditures (€33.40 Million). See BIO free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Biotest Aktiengesellschaft (2002–2024)
Capital reinvestment ratio of Biotest Aktiengesellschaft from 2002 to 2024. This chart tracks Biotest Aktiengesellschaft's Capital Reinvestment Ratio across 13 annual periods. See Biotest Aktiengesellschaft (BIO) flexibility index to measure the company's free cash flow as a share of total liabilities.
Biotest Aktiengesellschaft Capital Reinvestment Ratio by Year (2002–2024)
Biotest Aktiengesellschaft capital reinvestment ratio by year from 2002 to 2024. For the full cash flow conversion analysis, see Biotest Aktiengesellschaft operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.47x | €60.90 Million | €28.70 Million | ▼ -12.2% |
| 2021 | 0.54x | €33.90 Million | €18.20 Million | ▼ -82.7% |
| 2017 | 3.10x | €34.30 Million | €106.50 Million | ▲ +42.2% |
| 2016 | 2.18x | €65.90 Million | €143.90 Million | ▼ -17.4% |
| 2015 | 2.64x | €38.10 Million | €100.70 Million | ▲ +166.0% |
| 2012 | 0.99x | €34.73 Million | €34.51 Million | ▲ +168.8% |
| 2011 | 0.37x | €72.28 Million | €26.72 Million | ▼ -2.1% |
| 2010 | 0.38x | €77.83 Million | €29.37 Million | ▼ -70.2% |
| 2009 | 1.27x | €31.68 Million | €40.17 Million | ▲ +19.7% |
| 2008 | 1.06x | €34.49 Million | €36.54 Million | ▲ +43.9% |
| 2004 | 0.74x | €25.29 Million | €18.62 Million | ▼ -40.7% |
| 2003 | 1.24x | €16.52 Million | €20.51 Million | ▼ -90.1% |
| 2002 | 12.52x | €2.46 Million | €30.80 Million | — |